oct. 26, 2021
ACL Updates Gastrointestinal Pathogen Panel
Effective immediately, ACL Laboratories has changed the test methodology for the Gastrointestinal Pathogen Panel (Test Order Code LAB9037). There has been a significant shortage with molecular testing reagents due to the Covid-19 pandemic, which has made it difficult to obtain reagents for our current testing methodology.
oct. 04, 2021
High Sensitivity Troponin Implementation FAQ
ACL Laboratories will be replacing the current Troponin assay with a high sensitivity Troponin assay, on Thursday, October 21, 2021. High sensitivity Troponin (hs Troponin) assays have several benefits and clinical utility over the current contemporary assays.
oct. 04, 2021
ACL Offers High Sensitivity Troponin
Effective Thursday, October 21, 2021, ACL Laboratories will replace the current ultrasensitive Troponin I (TROPI) on the Siemens Vista and Dimension platforms with high sensitivity Troponin I (TROPIH).
oct. 04, 2021
ACL Converts Vaginal Pathogens to Hologic Aptima Assays
Effective Wednesday, October 20, 2021, ACL Laboratories will convert Vaginal Pathogens testing to one standardized platform on the Hologic® Panther® System.
sep. 08, 2021
August / September 2021 Test Bulletin
ACL Announces Changes to the Reporting of eGFR -- ACL Test Updates
jul. 29, 2021
July 2021 Test Bulletin
ACL Test Updates -- MLH1 Methylation (Test Order Code LAB9966) -- MGMT Methylation (Test Order Code LAB9946) -- Mosquito Borne Panel by PCR (Test Order Code LAB9947) -- Blastomyces Antibody, Complement Fixation (Test Order Code LAB9392) -- Phospholipase A2 Receptor (Test Order Code PLA2R) Ab, IgG w/Reflex to Titer -- …
mar. 04, 2021
March 2021 Test Bulletin
• Reporting of SARS-COV-2 Cycle Threshold (Ct) Values for Rapid SARS-COV-2 Testing (Advocate Aurora Health rapid testing only) • Organic Acids Screen, Urine (Test Order Code ORGUR) - New Performing Laboratory • ACL Announces Test Methodology Change for Inhibin B (Test Order Code INHIBB)
nov. 11, 2020
Important Announcement APTT Reference Range Changes
Effective midnight Tuesday, November 17, 2020, ACL Laboratories will standardize to a new lot of coagulation reagents and will begin using a new reference range, therapeutic range, and critical value for Activated Partial Thromboplastin Time (Test Order Code APTT).
aug. 17, 2020
National Shortage of Aptima Unisex Collection Kits
Due to the wide spread use of these collection devices, there is a national shortage of Aptima® Unisex collection devices used primarily for Chlamydia, Gonorrhea and/or Trichomonas laboratory testing.
Please read the attached document for additional information and alternative collection devices acceptable for Chlamydia and/or Gonorrhea testing.
aug. 14, 2020
Acceptable Specimen Collection Devices for SwabOne Testing
Effective August 24, 2020, ACL Laboratories will not be able to perform testing using ESwab™ as a collection device.
ACL Laboratories changed the methodology for Women’s Health SwabOne™ testing for vaginal pathogens effective Thursday, July 16, 2020. This new method is FDA approved and requires specimen (vaginal swab) collected using …
aug. 05, 2020
ACL Laboratories Discontinues In-House Testing for Viral Loads
Effective immediately, ACL Laboratories has discontinued in-house testing for the following tests:
• BKV Quantitative by PCR (BKVQN)
• BKV Quantitative by PCR, Urine (UKVQN)
• CMV Quantitative by PCR (CMVQN)
• EBV Quantitative by PCR (EBVQN)
• Blood Viral Panel Quantitative by PCR (BVPQN)
The reagent needed for these …
jul. 23, 2020
2020 Annual Physicians Report
ACL Laboratories maintains an active compliance program that reflects our commitment to conduct business in compliance with all federal, state and local laws. As a participant in federally funded health care programs, ACL Laboratories is required by the Office of Inspector General (OIG) and the US Department of Justice (DOJ) …
jul. 08, 2020
ACL Laboratories Revises SwabOne Testing Menu
Effective Thursday, July 16, 2020, ACL Laboratories will update the Women’s Health SwabOne™ testing menu for vaginal pathogens.
may. 14, 2020
ACL Offers Blood/Serology Testing for COVID-19
ACL Laboratories Offers Blood/Serology Testing for COVID-19
jan. 28, 2020
Important Announcement Novel Coronavirus Jan 2020
A cluster of pneumonia cases was first identified in Wuhan, China in December 2019. The causative agent of cases was later identified as a novel coronavirus that is currently being referred to as 2019-nCoV. It has also been referred to as Wuhan Virus. Within a matter of weeks, the …
nov. 08, 2019
November 2019 Test Bulletin
ACL Laboratories Changes Methodology for Trace Metal Testing -- 2020 CPT Code Changes -- ACL Laboratories Announces Changes in Instrument Platform for Free Kappa and Free Lambda Light Chains -- New Educational Resource for the Workup of Suspected Myeloproliferative Neoplasm (MPN)
aug. 19, 2019
September 2019 Test Bulletin
Total and Free PSA - Stability and Transport Requirement Changes
aug. 13, 2019
ACL Laboratories Makes Significant Changes to Susceptibility Testing
Effective immediately, ACL Laboratories, in conjunction with the Advocate Aurora Health Antimicrobial Stewardship Committee, made a series of significant changes to its microbiology susceptibility testing approaches.
jun. 28, 2019
July 2019 Test Bulletin
New Medicare Cards: Medicare Beneficiary ID (MBI) System Restrictions -- ACL Laboratories Announces New Test Swabone™ Mycoplasma Genitalium by TMA -- (Test Order Code SWOMG) -- ACL Laboratories Discontinues In-House Testing for Test Order Codes:
HIVGEN, HIVING, TOXPCR and PRVB19 -- ACL Testing Methodology Changes from Rapid Antigen/Culture Techniques to …
may. 29, 2019
June 2019 Test Bulletin
Heparin Dependent Antibody (PF4IGG, PF4IGR & HDA) Sample Requirements Change -- New Syphilis Total Antibody Assay (Test Order Code SYPT)